RETA — Reata Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge Cap

Annual balance sheet for Reata Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	338	664	818	590	388
Net Total Receivables	—	—	22.2	0	—
Prepaid Expenses
Total Current Assets	342	669	847	596	398
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.45	12.1	10.1	138	116
Other Long Term Assets
Total Assets	345	682	858	735	514
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	55.9	192	119	54	59
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	330	426	440	549	580
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	15.2	257	417	186	-65.7
Total Liabilities & Shareholders' Equity	345	682	858	735	514
Total Common Shares Outstanding